Cargando…
PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428854/ http://dx.doi.org/10.1097/01.HS9.0000976756.95685.44 |
_version_ | 1785090570022027264 |
---|---|
author | Meunier, Benoit Manceau, Sandra Corsia, Alice Ihlem, Rahal Jestin, Mathhieu Verheyden, Laetitia Lefrère, François Cavazzana, Marina Arlet, Jean-Benoît Joseph, Laure |
author_facet | Meunier, Benoit Manceau, Sandra Corsia, Alice Ihlem, Rahal Jestin, Mathhieu Verheyden, Laetitia Lefrère, François Cavazzana, Marina Arlet, Jean-Benoît Joseph, Laure |
author_sort | Meunier, Benoit |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428854 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104288542023-08-17 PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE Meunier, Benoit Manceau, Sandra Corsia, Alice Ihlem, Rahal Jestin, Mathhieu Verheyden, Laetitia Lefrère, François Cavazzana, Marina Arlet, Jean-Benoît Joseph, Laure Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428854/ http://dx.doi.org/10.1097/01.HS9.0000976756.95685.44 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Meunier, Benoit Manceau, Sandra Corsia, Alice Ihlem, Rahal Jestin, Mathhieu Verheyden, Laetitia Lefrère, François Cavazzana, Marina Arlet, Jean-Benoît Joseph, Laure PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE |
title | PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE |
title_full | PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE |
title_fullStr | PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE |
title_full_unstemmed | PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE |
title_short | PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE |
title_sort | pb2514: immunogenicity of anti-sars-cov-2 vaccines in patients with severe sickle cell disease |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428854/ http://dx.doi.org/10.1097/01.HS9.0000976756.95685.44 |
work_keys_str_mv | AT meunierbenoit pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT manceausandra pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT corsiaalice pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT ihlemrahal pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT jestinmathhieu pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT verheydenlaetitia pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT lefrerefrancois pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT cavazzanamarina pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT arletjeanbenoit pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease AT josephlaure pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease |